Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 22;11(1):9.
doi: 10.1186/s13073-019-0622-1.

Translating genomic medicine to the clinic: challenges and opportunities

Huan Zhang  1   2 , Lars Klareskog  3 , Andreas Matussek  4 , Stefan M Pfister  5   6   7   8 , Mikael Benson  9   10
Affiliations
Review

Translating genomic medicine to the clinic: challenges and opportunities

Huan Zhang et al. Genome Med. .

Abstract

Genomic medicine has considerable potential to provide novel diagnostic and therapeutic solutions for patients who have molecularly complex diseases and who are not responding to existing therapies. To bridge the gap between genomic medicine and clinical practice, integration of various data types, resources, and joint international initiatives will be required.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Dzau VJ, Ginsburg GS, Van Nuys K, Agus D, Goldman D. Aligning incentives to fulfil the promise of personalised medicine. Lancet. 2015;385:2118–2119. doi: 10.1016/S0140-6736(15)60722-X. - DOI - PMC - PubMed
    1. Letai A. Functional precision cancer medicine—moving beyond pure genomics. Nat Med. 2017;23:1028. doi: 10.1038/nm.4389. - DOI - PubMed
    1. Stranneheim H, Wedell A. Exome and genome sequencing: a revolution for the discovery and diagnosis of monogenic disorders. J Intern Med. 2016;279:3–15. doi: 10.1111/joim.12399. - DOI - PubMed
    1. Le Tourneau C, Delord J-P, Gonçalves A, Gavoille C, Dubot C, Isambert N, et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol. 2015;16:1324–1334. doi: 10.1016/S1470-2045(15)00188-6. - DOI - PubMed
    1. Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, et al. Defining a cancer dependency map. Cell. 2017;170:564–576. doi: 10.1016/j.cell.2017.06.010. - DOI - PMC - PubMed

Publication types

MeSH terms